The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells
Pre-publication versions of this article are available by contacting email@example.com.
|27 May 2010||Submitted||Original manuscript|
|30 Jul 2010||Reviewed||Reviewer Report - James Mier|
|10 Aug 2010||Reviewed||Reviewer Report - Pier Giorgio Petronini|
|16 Aug 2010||Reviewed||Reviewer Report - Paola Ulivi|
|16 Aug 2010||Reviewed||Reviewer Report - Roberto R. Rosato|
|10 Sep 2010||Author responded||Author comments - Christian Junghanss|
|Resubmission - Version 2|
|10 Sep 2010||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|15 Sep 2010||Author responded||Author comments - Christian Junghanss|
|Resubmission - Version 4|
|15 Sep 2010||Submitted||Manuscript version 4|
|15 Oct 2010||Editorially accepted|
|15 Oct 2010||Article published||10.1186/1471-2407-10-560|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.